Earnings per share during the quarter were $1.62, compared with the $1.53 analysts expected on average, according to research firm LSEG, CNBC reports.
Revenue came in at $68.13 billion, while analysts expected $66.2 billion on average.
This means that revenue increased by 73 percent compared to the same period a year earlier, when it reached $39.3 billion.
Wednesday's figures represent the eleventh consecutive quarter with sales growth of over 55 percent.
Even higher growth rate
Nvidia expects even higher growth rates in the current quarter, which runs until the end of April, with revenue likely to reach around $78 billion - well above the expected $72.6 billion.
The company's expectations for the future are also brighter than analysts had expected. And that in itself sends a positive signal, says Felicia Schön.
She emphasizes that these are still forecasts in a troubled industry, where Nvidia is greatly influenced by demand from other AI companies.
But as it stands right now, everything still seems stable.
In the fourth quarter, the data center business area was a major contributor to the company's success, generating revenue of $62.3 billion, up 75 percent from a year ago.
This will be a temporary respite, but the concern in this sector remains - that's because of these extremely large investments that all companies in the AI sector are making. They want to see that it actually becomes profitable. So we probably haven't heard the last of the AI bubble this time, says Schön.
Rising in after-hours trading
About 40 minutes after the report was released, Nvidia's stock had risen about 2 percent in after-hours trading on the New York Stock Exchange.
California-based Nvidia - valued at just over $4.5 trillion (nearly SEK 41 trillion) - is the company at the center of the AI boom.
Many of the other major technology companies are customers of Nvidia in their own AI expansions, and at the same time competitors in other areas.
Nvidia's market capitalization is well over three times the total value of the entire Stockholm Stock Exchange, including large secondary listings such as AstraZeneca and ABB.
